BDBM299134 (6S,8R)-7-(2- fluoro-2- methylpropyl)-6- (2-methoxy-4- (2-(3- methylazetidin- 1-yl)ethoxy) phenyl)-8- methyl-6,7,8,9- tetrahydro-3H- pyrazolo[4,3- f]isoquinoline::US10125135, Example 23

SMILES COc1cc(OCCN2CC(C)C2)ccc1[C@H]1N(CC(C)(C)F)[C@H](C)Cc2c1ccc1[nH]ncc21

InChI Key InChIKey=RTEGWASSUYQZHF-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 299134   

TargetEstrogen receptor(Human)
Astrazeneca

US Patent
LigandPNGBDBM299134(US10125135, Example 23 | (6S,8R)-7-(2- fluoro-2- m...)
Affinity DataIC50: 2.80nMAssay Description:The ability of compounds to bind to isolated Estrogen Receptor Alpha Ligand binding domain (ER alpha LBD (GST)) was assessed in competition assays us...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/11/2019
Entry Details
US Patent